Cargando…

Weight Loss Mobile Apps: Do They Address COVID-19 and Diabetes

Background: Over 70 million Americans are obese and 99 million are overweight. There are over 3.7 billion ehealth mobile app downloads per year. Weight loss apps offer information on exercise and nutrition as well as weight tracking. Obesity is a risk factor for COVID-19 infection, along with diabet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Gloria, Nguyen, Brian, Lau, Chap-Kay Kendra, Siu, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135301/ http://dx.doi.org/10.1210/jendso/bvab048.060

Ejemplares similares

ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
por: Lawrence, Rebecca, et al.
Publicado: (2022)

Is Insulin Resistance at Baseline a Predictor of Weight Loss After Bariatric Surgery?
por: Borges-Canha, Marta, et al.
Publicado: (2021)

Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
por: Mosenzon, Ofri, et al.
Publicado: (2021)

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

SAT-095 The Impact of CPAP on Intensive Calorie Restriction Weight Loss
por: Mao, Yuanjie, et al.
Publicado: (2019)

MON-LB100 Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospectiveanalysisof 1,567 Patientswith Obesity With Successful Clinical Weight-Loss Approaches
por: Cadegiani, Flavio, et al.
Publicado: (2020)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

FRI074 Rise In Fasting Ghrelin Level In Response To Weight Loss Predicts Future Weight Regain In The POUNDS LOST Trial
por: Tong, Jenny, et al.
Publicado: (2023)

MON-590 Presence of Diabetes Diminishes the Ultimate Weight Loss After Bariatric Surgery
por: Luo, Yingying, et al.
Publicado: (2020)

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
por: Huynh, Kim D, et al.
Publicado: (2021)

Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
por: John, Linu M, et al.
Publicado: (2021)

OR10-03 Murine Bimagrumab Co-administration With Incretin Agonists Results In Additive Efficacy And Superior Quality Weight Loss In The Mouse Diet-induced Obesity Model
por: Nguyen, Kevin, et al.
Publicado: (2023)

MON-109 Identifying Limiting Factors to Weight Loss and Prevention of Comorbidities in a Patient Population with Obesity
por: Johns, Allison, et al.
Publicado: (2019)

MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020)

Engagement in a Multi-Feature Digital Health Lifestyle Change Program as a Predictor of Weight Loss
por: Dzubur, Eldin, et al.
Publicado: (2021)

ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)

OR10-3 Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study
por: Andre, Clarissa, et al.
Publicado: (2022)

FRI075 Single Center Retrospective Matched Cohort Study Of glp1ra-induced Weight Loss In Patients With Post-bariatric Weight Regain Vs Non-surgical Controls
por: Carmen Rivadeneira, Ana Del, et al.
Publicado: (2023)

ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy
por: Nguyen, Vivien, et al.
Publicado: (2022)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial
por: Fox, Claudia K, et al.
Publicado: (2021)

No Differences in Metabolic Parameters Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy, Regardless of Achieved Weight Loss
por: Holanda, Narriane Chaves Pereira, et al.
Publicado: (2021)

Neurobiology of Avoidant/Restrictive Food Intake Disorder in Youth With Overweight/Obesity Versus Healthy Weight
por: Liya, Kerem, et al.
Publicado: (2021)

SAT-119 Effect of Binge Eating Diagnosed Prior to Bariatric Surgery on Weight Loss up to 2 Years after Surgery
por: Friedman, Rogerio, et al.
Publicado: (2019)

SAT-108 Effects of Bariatric and Non-Bariatric Weight Loss on Migraine Headache in Obesity. A Systematic Review and Meta-Analysis
por: Di Vincenzo, Angelo, et al.
Publicado: (2019)

Low Health Literate State Does Not Negatively Affect Final Weight Loss After a Laparoscopic Gastric Bypass Procedure
por: Twickler, Theodorus Bartholomeus, et al.
Publicado: (2021)

MON-LB107 Treat: A Randomized Controlled Trial Examining the Effects of Time Restricted Eating on Weight Loss and Metabolic Markers
por: Lowe, Dylan A, et al.
Publicado: (2020)

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)
por: Rubino, Domenica M, et al.
Publicado: (2021)

OR10-02 Effect Of Phosphodiesterase 4 Inhibitors On Weight Loss And Energy Homeostasis In Mice With Obesity Induced By A High-fat-diet
por: de Andrade, Maria Amelia A M, et al.
Publicado: (2023)

FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist
por: Fansa, Sima, et al.
Publicado: (2023)

Higher Peptide YY Levels Are Associated With Lower Bone Mineral Density in Low Weight Adolescent Girls With Avoidant/Restrictive Food Intake Disorder
por: Sella, Aluma Chovel, et al.
Publicado: (2021)

MON-LB019 Setmelanotide (RM-493) Reduces Food Intake and Rapidly Induces Weight Loss in a Mouse Model of Alström Syndrome
por: Stephenson, Erin, et al.
Publicado: (2019)

SUN-113 Adipocyte Morphology And Cytokine Gene Expression In Adipose Tissue From Patients Before And After Weight Loss From Bariatric Surgery
por: Casimiro, Isabel, et al.
Publicado: (2019)

SAT-LB019 Improvement of Visceral Fat and Body Composition Endpoints in Participants on Prescription Thyroid Replacement with a Doctor-Supervised Weight Loss Program
por: Dembrowski, Gerald, et al.
Publicado: (2019)

SAT675 GLP-1RA Therapy And Intussusception: A Case Report Of Bowel Telescoping In Anobese Patient After Successful Weight Loss On Therapy
por: Alqaisi, Sura, et al.
Publicado: (2023)

Safety and Tolerability of Concomitant Administration of Multiple-Dose AM833 With Semaglutide 2.4 MG for Weight Management
por: Enebo, Lone B, et al.
Publicado: (2021)

SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study
por: Greenway, Frank, et al.
Publicado: (2019)

SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

PSUN124 Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery
por: Bomberg, Eric M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d4cskmb21hvjeahpo5tl5pfrt0